ROCHE HOLDING BJ Stock Euronext Paris
Stocks
MLROH
CH0012032048
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| 07-15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 07-15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
| Market Cap | 263B 326B 326B 285B 242B 459B 31,406B 466B 3,143B 1,233B 15,351B 1,226B 1,199B 52,909B | P/E 2026 * |
17.6x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 274B 339B 339B 297B 252B 477B 32,665B 485B 3,269B 1,283B 15,966B 1,275B 1,247B 55,031B | EV / Sales 2026 * |
4.37x | EV / Sales 2027 * | 4.09x |
| Free-Float |
88.78% | Yield 2026 * |
3.03% | Yield 2027 * | 3.1% |
Last Transcript: ROCHE HOLDING BJ
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | -4.87% | +49.87% | +157.34% | 1,031B | |
| -2.69% | -6.22% | +59.19% | +54.51% | 595B | |
| -0.27% | -3.41% | +30.97% | +79.48% | 431B | |
| -0.13% | -2.16% | +27.86% | +43.22% | 277B | |
| -0.89% | -6.86% | +19.18% | +21.94% | 263B | |
| +1.07% | +4.04% | -23.18% | -37.85% | 224B | |
| +0.86% | -2.63% | +22.50% | +57.55% | 193B | |
| +1.28% | -3.03% | +20.76% | +70.62% | 164B | |
| +2.35% | +3.20% | +0.85% | -31.66% | 141B | |
| Average | +0.36% | -3.28% | +23.11% | +46.13% | 368.82B | |
| Weighted average by Cap. | +0.31% | -4.27% | +34.77% | +77.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.6B 77.62B 77.62B 67.86B 57.54B 109B 7,468B 111B 747B 293B 3,650B 291B 285B 12,582B | 65.29B 80.95B 80.95B 70.77B 60.01B 114B 7,789B 116B 779B 306B 3,807B 304B 297B 13,122B |
| Net income | 15.22B 18.88B 18.88B 16.5B 14B 26.52B 1,816B 26.97B 182B 71.32B 888B 70.89B 69.34B 3,060B | 16.35B 20.27B 20.27B 17.72B 15.03B 28.47B 1,950B 28.96B 195B 76.58B 953B 76.12B 74.45B 3,286B |
| Net Debt | 10.56B 13.09B 13.09B 11.44B 9.7B 18.38B 1,259B 18.7B 126B 49.44B 616B 49.15B 48.07B 2,121B | 3.92B 4.85B 4.85B 4.24B 3.6B 6.82B 467B 6.94B 46.74B 18.34B 228B 18.23B 17.83B 787B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ROP Stock
- MLROH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
